Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211

BACKGROUND: Lack of functional CCR5 increases the severity of certain viral infections, including West Nile virus and tickborne encephalitis. In a phase II trial of the investigational CCR5 antagonist vicriviroc (AIDS Clinical Trials Group protocol A5211), 4 lymphomas occurred in study patients who...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tsibris, Athe M. N., Paredes, Roger, Chadburn, Amy, Su, Zhaohui, Henrich, Timothy J., Krambrink, Amy, Hughes, Michael D., Aberg, Judith A., Currier, Judith S., Tashima, Karen, Godfrey, Catherine, Greaves, Wayne, Flexner, Charles, Skolnik, Paul R., Wilkin, Timothy J., Gulick, Roy M., Kuritzkes, Daniel R.
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2756462/
https://ncbi.nlm.nih.gov/pubmed/19191652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/597007
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires